The KBiosystems Automated Adhesive Microplate Sealing System is a reliable instrument allowing ease of use and flexible allowing manual use and robotic integration. The KAPS-500 is a reliable and robust Microplate Sealer with variable roller sealing pressure ensures consistent sealing with minimal user intervention.
The KAPS-500 is integrator friendly and uses a RS232 interface and is capable of up to 300 plates per hour. The flexibility of the sealer enables cross application use of the instrument to include, PCR, QPCR and crystallography amongst others. As with all KBiosystems sealing systems, the KAPS-500 can use all seal types that include breathable, pierceable, optically clear and all other adhesion based seals.
Operator Friendly – Touch Screen allows fast and easy manual operation as a standalone product
Adaptable – The KAPS-500 will automatically adjust allowing the instrument to be used with a wide range of microplates and tube rack with plate stage inserts to allow use of more unusual microplate types as well as variable roller pressure sensors.
Fast – With fast sealing times allows 300 plates to be sealed per hour.
Versatile – Able to use all seal types across a large number of applications.
Reliable – Engineered with robustness in mind Perfect for Integration – Integration friendly with a large number of integrated systems already in place globally.
Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Enzyme Links Age-Related Inflammation, Cancer Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration. New Biomarker to Assess Stem Cells Developed A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.Therapy Halts Progression of Lou Gehrig’s Disease Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.Crouching Protein, Hidden Enzyme A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.HIV Protein Manipulates Hundreds of Human Genes Findings search for new or improved treatments for patients with AIDS.First 3-D Vision of Cancer Target This basic research set the grounds for structure-based drug design approaches that could be beneficial for cancer treatments' - Dr. Cyril Dominguez, University of Leicester.New Light Shed on Genetic Regulation A team of scientists has uncovered greater intricacy in protein signaling than was previously understood, shedding new light on the nature of genetic production.Hacking the Programs of Cancer Stem Cells All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.